Stay updated on Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Sign up to get notified when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.

Latest updates to the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record remains unchanged.SummaryDifference0.1%

- Check9 days agoChange DetectedA notice was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference0.9%

- Check16 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedThe site footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check44 days agoChange DetectedThe study record history now shows a new revision tag v3.7.0, replacing the previous v3.6.6, indicating a software update to the page rendering rather than changes to the study data.SummaryDifference0.1%

- Check64 days agoChange DetectedThe study record history shows a new version, updating from v3.6.5 to v3.6.6. This indicates an internal revision to the page metadata and does not reflect substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.